儿童银屑病共病筛查指南
因儿童研究有限,推荐强度为SORT C级专家共识;多数推荐与美国儿科学会通用儿科建议一致,并强调关注关节炎、抑郁和焦虑的症状体征。
要点
- 儿童银屑病患者应常规筛查共病危险因素
- 多数推荐与美国儿科学会通用儿科建议一致
- 需额外关注关节炎、抑郁和焦虑的症状与体征
核心结论
- 儿童银屑病患者应接受常规筛查并识别相关共病危险因素。
- 这些指南适用于所有照护儿童银屑病患者的医疗提供者,包括基层临床医生、皮肤科医生和儿科专科医生。
- 由于是首部儿童指南,随着研究进一步细化风险,需重新审查和完善。
研究设计与样本
- 制定机构为多学科专家组,涵盖银屑病、儿童皮肤科、儿童风湿科、儿童消化科、儿童内分泌科及成人与儿童心脏科。
- 采用以患者为中心的推荐强度分类法(SORT)评价证据质量。
主要发现
- 因儿童研究数量有限,专家组推荐强度归类为SORT C级专家共识推荐。
- 多数推荐与美国儿科学会针对一般儿科患者的建议一致,但额外关注关节炎、抑郁和焦虑的症状与体征。
- 专家组还确定了需进一步研究的关键领域。
关键数值与推荐
- 推荐强度为SORT C级专家共识推荐。
临床怎么用
- 对儿童银屑病患者进行常规筛查,识别相关共病的危险因素。
- 在遵循美国儿科学会通用儿科建议基础上,额外关注关节炎、抑郁和焦虑的症状与体征。
- 基层临床医生、皮肤科医生和儿科专科医生均可参照本指南。
局限性
- 儿童相关研究数量有限,导致推荐强度仅为SORT C级专家共识。
- 作为首部儿童指南,需随研究进展重新审查和完善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Psoriasis is a complex inflammatory skin condition associated with serious medical comorbidities in adults, including obesity, hypertension, dyslipidemia, type 2 diabetes mellitus, psoriatic arthritis, nonalcoholic fatty liver disease, depression, anxiety, and decreased quality of life. Because psoriasis begins in childhood in almost one-third of patients, early identification of risk may be critical to minimizing effects on future health. OBJECTIVE: To develop the first set of guidelines for comorbidity screening for patients with pediatric psoriasis based on current evidence. EVIDENCE REVIEW: A literature review was performed using PubMed from January 1999 through December 2015. Limiting the search to human studies published in English and removing reviews and editorials produced 153 relevant manuscripts. An expert panel in psoriasis, pediatric dermatology, pediatric rheumatology, pediatric gastroenterology, pediatric endocrinology, and adult and pediatric cardiology used the patient-centered Strength of Recommendation Taxonomy (SORT) method to evaluate and grade the quality of evidence. FINDINGS: Because of the limited number of pediatric studies published on these topics, the strength of the panel's recommendations is classified as SORT level C expert consensus recommendations. The majority of recommendations coincide with those endorsed by the American Academy of Pediatrics for the general pediatric patient but with added attention to signs and symptoms of arthritis, depression, and anxiety. The panel also identified key areas for further investigation. CONCLUSIONS AND RELEVANCE: Patients with pediatric psoriasis should receive routine screening and identification of risk factors for associated comorbidities. These guidelines are relevant for all health care providers caring for patients with pediatric psoriasis, including primary care clinicians, dermatologists, and pediatric specialists. Because these are the first pediatric guidelines, re-review and refinement will be necessary as studies further detail, and possibly stratify, risk in affected children.
引用
- Osier E, Wang AS, Tollefson MM, et al. Pediatric Psoriasis Comorbidity Screening Guidelines. JAMA Dermatol. 2017. PMID: 28514463. doi:10.1001/jamadermatol.2017.0499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。